propantheline has been researched along with Neurally Mediated Faint in 1 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, beta-blockers for neurocardiogenic syncope are often not tolerated or are ineffective." | 2.68 | Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications. ( Sung, RJ; Yu, JC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, JC | 1 |
| Sung, RJ | 1 |
1 trial available for propantheline and Neurally Mediated Faint
| Article | Year |
|---|---|
Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications.
Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Parasympatholyt | 1997 |